News

Finalizing the Investment in Auxilius Pharma: A Strategic Step in Building a Biotechnology Group

NanoGroup S.A. announced today, December 17, 2025, the closing of a 7.5 million PLN investment in Auxilius Pharma S.A. as part of a funding …

New investors among NanoGroup shareholders. Company raises more than PLN 10 million

NanoGroup S.A. signed an investment agreement for PLN 10.55 million with its main shareholder, Michal Lach, who simultaneously paid PLN 10.1 million. The funds …

Secure innovation, predictable returns – new Development Strategy 2026 – 2028

NanoGroup S.A. has adopted a Development Strategy for 2026-2028, with the main goal of achieving a position in the TOP3 of Polish biotechnology g…

NanoGroup Invests in Auxilius Pharma – Value Added Medications

NanoGroup is strategically expanding its portfolio to include the Value Added Medications (VAM, value-added drugs) segment, by financing a PLN 7….

NanoGroup’s PLN 11.9 million bioadsorber project moves to final stage of evaluation

NanoSanguis, a subsidiary of NanoGroup, has successfully passed the first stage of evaluation of the submitted grant application for the project “Spe…

NanoGroup unveils the first unit of the NanOX Recovery Box organ perfusion device. Innovative solution enters engineering testing stage and prepares for certification

NanoGroup S.A., a WSE-listed company developing innovative medical technologies, has unveiled the first unit of the NanOX Recovery Box organ perfusion devi…

Media resources

Company logo

logotype.zip (1.27 MB)
Download
pp-thumbnail